Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making
- 2 February 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 27 (4), 661-663
- https://doi.org/10.1183/09031936.06.00017406
Abstract
A new influenza pandemic is inevitable. The type A H5N1 avian influenza is a potential pandemic threat. This influenza virus is currently circulating in Asia and has appeared in other regions, including Europe, the Middle East and Africa. More than 150 million birds have died from the virus or have been killed in an attempt to limit its spread. It has been transmitted from birds to humans on a limited basis. The reported human fatality rate is >50%, based on at least 91 deaths among at least 169 confirmed cases reported to the World Health Organization (WHO) since December 2003.Keywords
This publication has 7 references indexed in Scilit:
- Antivirals for influenza in healthy adults: systematic reviewThe Lancet, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Characterization of the 1918 influenza virus polymerase genesNature, 2005
- Efficacy and effectiveness of influenza vaccines in elderly people: a systematic reviewThe Lancet, 2005
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005
- Prevention of influenza in the general populationCMAJ : Canadian Medical Association Journal, 2004
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of Internal Medicine, 2003